A leading scientist behind the University of Oxford’s potential Covid-19 vaccine said the team has seen the right sort of immune response in trials but declined to give a firm time frame for when it could be ready, Reuters reported.
Speaking at a parliamentary hearing, Sarah Gilbert, professor of vaccinology at the university, said 8,000 volunteers had been enrolled for the Phase III of its trial into the vaccine, AZD1222, which was licensed to AstraZeneca.
“We’re very happy that we’re seeing the right sort of immune response that will give protection, and not the wrong sort,” Gilbert said.
Read the full story here.
